Background: The aim of the study was to evaluate the use of enamel matrix derivative (EMD) alone or in association with deproteinized bovine bone mineral (DBBM) for the treatment of partially contained intrabony defects. Methods: A total of 20 two-walled intrabony defects belonging to nine patients were included. Ten defects were treated with EMD alone (test group 1) and the other 10 were treated with EMD and DBBM (test group 2), applying either modified papilla preservation technique or simplified papilla preservation technique. Results: Twelve months after surgery, in the test group 1, PD was 2.8 AE 0.8 mm, REC was 2.3 AE 2.4 mm and CAL was 5.0 AE 2.8 mm, significantly reduced from baseline values (P < 0.05). Likewise, in test group 2, PD, REC and CAL reduced to 3.0 AE 0.7 mm, 3.9 AE 1.5 mm and 6.9 AE 1.1 mm respectively, from baseline values at 12 months (P < 0.05). No significant differences between groups were found.
INTRODUCTION
Intrabony defects of the alveolar bone develop as a result of vertical periodontal bone resorption, which creates defects whose base is located apically to the bone crest.
A number of conditions have been related to the development of an intrabony defect, from the vascularization of the alveolar bone, to the shape of the cemento-enamel junction (CEJ) of the involved tooth, and to the width and thickness of the alveolar and interproximal bone. [1] [2] [3] Moreover, it has been speculated that the interradicular distance between two adjacent teeth could also play an important role in determining the formation of a vertical bone defect. [4] [5] [6] [7] From an epidemiological point of view, intrabony defects seem to be more represented in second molars, 3 in particular in the lower jaw. 2 Recently, an epidemiological study evaluated the prevalence of intrabony defects in a cohort of 329 adults, through clinical and radiographic examination. 8 The authors
showed that the prevalence of such vertical defects was 2.2% at tooth level (4.1% of molars and 1.5% of non-molars) and confirmed the higher prevalence in mandibular second molars. These data are in line with the results of an epidemiological study by Vrotsos et al., published in 1999. 9 Interestingly, Najim et al. found that the risk of having an intrabony defect in subjects aged 60 or older is almost three times higher than in 40-year-old subjects. 8 Furthermore, smoking was significantly correlated to the development of intrabony defects (OR = 2.85), as well as periodontitis (OR = 9.58). 8 The need for surgical treatment for residual deep periodontal pockets after initial non-surgical periodontal therapy has been justified by several published studies suggesting the need to treat sites showing PD of 5 mm or more. [10] [11] [12] These assumptions are consistent with those presented in a more recent study. 13 A number of surgical techniques and biomaterials have been employed for the regenerative treatment of intrabony defects. Bone substitutes have been successfully applied alone or in association with a barrier 
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The official journal of the Australian Dental Association membrane (according to the guided tissue regeneration principle) to fill intrabony defects. 14, 15 Enamel matrix derivative (EMD) has been proven effective in stimulating the periodontal ligament cells to regenerate the periodontal tissues that were lost due to an inflammatory process, 16, 17 particularly in self-contained defects (mostly three-walled). 17 Remarkably, the combination of bone substitutes with bioactive materials (such as EMD) has been associated with enhanced results, as it combines the osteoconductive and space-making properties of bone grafts with the ability of bioactive materials to stimulate periodontal regeneration. 18, 19 Even though such materials have been proven to be effective for the treatment of intrabony defects, little has been said about the specific indications of different materials or their association in relation with the morphology of the defects.
The main aim of the present study was to compare the use of EMD alone or in association with a deproteinized bovine bone mineral (DBBM) graft for the treatment of partially contained intrabony defects, by evaluating clinical and radiographic outcomes 12 months after surgical intervention. The null hypothesis was that both treatments were equally effective for the treatment of this particular type of periodontal defects.
MATERIALS AND METHODS
This is a non-randomized controlled study.
The study protocol was approved by the Review Board of the Research Centre for Oral Implantology (CRIO), Universit a degli Studi di Milano in Milan, Italy in 2015. The present paper was structured following the guidelines of the Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) statement. 20 All procedures performed were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Participants
Participants were recruited from patients attending the Dental Clinic of the IRCCS Istituto Ortopedico Galeazzi in Milan, Italy from January 2015 to January 2016. The main inclusion criteria were presence of chronic periodontitis (following the classification described by Armitage in 1999 21 and presence of one or more residual periodontal intrabony defects of more than 4 mm, evaluated after periodontal non-surgical treatment through periodontal probing and visualization of periapical radiographs. Further inclusion criteria were: age 18 years old or older, patients able to understand and sign a written informed consent form, patients without any relative or absolute contraindication to surgical intervention (ASA-1 or ASA-2 following the classification proposed by the American Society of Anaesthesiologists)), patients having full-mouth bleeding score of less than 25% and fullmouth plaque score of less than 25%, and non-smoking patients or patients smoking less than five cigarettes a day. Patients with one-walled defects, being pregnant, or nursing were excluded.
Clinical data were collected in the Dental Clinic of the IRCCS Istituto Ortopedico Galeazzi in Milan, Italy.
Interventions
All patients were informed about the available treatment options and signed an informed consent form before the beginning of the intervention. All surgeries were performed by one operator (SC) with more than 5 years of experience in periodontal surgery. Before surgery, patients were instructed to rinse for 60 s with 0.15 mL of a solution of chlorhexidine digluconate 0.2%. Then, local anaesthesia was obtained through deep injections vestibular in the fornix and on the lingual side with Articaine 4% with epinephrine 1:100 000. After achieving a complete anaesthesia of the area, a mucoperiosteal flap was carefully elevated following the protocols described by Cortellini et al. 22, 23 (Modified Papilla Preservation Technique and Simplified Papilla Preservation Technique) and trying to preserve the tissue of the interdental papilla in the region of the bony defect. A thorough debridement of the granulation tissue from the defect was performed with manual and ultrasonic instruments. The direct visualization of the defects permitted to confirm their classification on the basis of the number of remaining walls as partially contained (two-walled) defects. The defects were treated either with EMD alone (test group 1) or with EMD combined with DBBM (test group 2).
In detail, in both groups, after conditioning the root surface for 2 min with 24% EDTA gel (Straumann ; Geistlich Pharma AG, Wolhusen, Switzerland) was mixed with EMD gel and placed in the defect and afterwards before suturing the flap with 5/0 and 6/0 nylon sutures (ETHILON â ). The patients were advised to avoid any trauma or traction in the surgical area and not to consume hard food during the first 5 days. Ibuprofen 400 mg was prescribed twice a day for 3 days for inflammation control and pain relief. Tooth-brushing in the region of surgery was avoided for 2 weeks and plaque control was obtained with 1% chlorhexidine digluconate gel, applied three times a day. After this period, the patients were instructed to resume tooth-brushing using ultra-soft bristles for two more weeks, before reintroducing standard oral hygiene procedures. Sutures were removed 7 days after surgery.
Outcomes
The primary outcome was the clinical attachment level (CAL) measured as the distance between the cemento-enamel junction and the bottom of the pocket.
The secondary outcomes were: (a)Probing depth (PD) measured as the distance between the gingival margin and the bottom of the pocket (b)Recession (REC) measured as the distance between the gingival margin and the cemento-enamel junction (if visible) (c)Radiographic fill of the defect evaluated through comparison of periapical radiographs taken before intervention and during the follow-up visits. More specifically, the distance between the cementoenamel junction and the bottom of the defect (CEJ-A), the distance between the projection of the bone crest to the root surface and the bottom of the defect (representing the intrabony portion of the defect, C-A), and the distance between the bone crest and the root surface (representing the maximum width of the defect, C-B) were measured ( Fig. 1 ). (d)The occurrence of complications in the postoperative period (e)The radiographic evidence of the formation of the 'lamina dura' at 6 and 12 months, intending the radiographic image of the presence of cortical bone in the area of the defect. Furthermore, the presence of plaque and bleeding on probing was recorded in the site of intervention.
All clinical measures (PD, REC, CAL, plaque and bleeding on probing) were taken by one experienced, previously calibrated, blinded operator (AA) and recorded at baseline, 6 and 12 months after surgery. These measures were taken using a periodontal probe with University of North Carolina markings (UNC-15). Radiographic evaluation was performed by the same blind examiner (AA), who compared periapical radiographs taken at baseline, 6 and 12 months after surgical intervention. The software ImageJ (Rasband, W.S., ImageJ; U. S. National Institutes of Health, Bethesda, MD, USA, https://imagej.nih.gov/ij/, 1997-2016.) was used for all radiographic measurements.
Assignment method
The defects were alternatively allocated to Test group 1 and to the Test group 2 by one operator (LF). A number was assigned to each defect and this identification code was used to guarantee blinding in data collection and analysis.
Statistical methods and analysis
Statistical analysis was performed by one blind operator (SC). The unit of the analysis was the single intrabony defect. Descriptive statistics, including mean values, standard deviation, median and confidence interval were provided for all quantitative variables (PD, REC, CAL and radiographic outcomes). Frequencies of plaque accumulation and of bleeding on probing sites were calculated.
The Shapiro-Wilk test was used to assess the normality of distribution of PD, REC, CAL and Fig. 1 Graphical representation of measurements made on periapical radiographs.
radiographic outcomes values. The unpaired Student's t-test was used to assess between-group differences for all evaluated outcomes. Paired Student's t-test was used to evaluate the within-group difference between baseline, 6 and 12 months. The level of significance was set at P < 0.05.
Linear regression was the method used to detect the influence of baseline patient's demographic data (age, sex) and defect's characteristics (classification, PD, REC, CAL, radiographic features) on the changes in clinical and radiographic outcomes after 6 and 12 months (level of significance P < 0.05) Statistical analysis was performed using the software package IBM SPSS Statistics version 22 (IBM, Armonk, NY, USA).
RESULTS
A total of 21 intrabony defects in 10 patients were included in the study. One defect belonging to one patient and allocated to control group was excluded from the data analysis because the patient did not attend the required follow-up appointments. The presented results are therefore, from 20 defects belonging to 9 patients. No surgical or postoperative complications were reported. Figures 2 and 3 show two of the treated cases.
The baseline demographic characteristics of the patients are presented in Table 1 . Table 2 shows absolute values of the clinical outcomes recorded before treatment, 6 and 12 months after treatment. Table 3 shows the radiographic outcomes.
At 12 months, the mean PD decreased by 57.9 AE 22.3% (4.9 AE 3.0 mm) compared to baseline in the test group 1, and by 68.7 AE 14.9% (5.9 AE 1.6 mm). The REC mean value increased by 0.6 AE 1.1 mm in the test group 1 and by 0.7 AE 2.3 mm in test group 2. The mean CEJ-A decreased by 42.7 AE 29.1% (3.9 AE 3.2 mm) in the test group 1 and by 43.3 AE 25.0% (5.5 AE 3.1 mm) in the test group 2. The mean C-A decreased by 3.0 AE 1.7 mm in the test group 1 and by 3.4 AE 2.5 mm in the test group 2, whilst the mean C-B decreased by 1.0 AE 0.9 mm in the test group 1 and by 1.2 AE 1.3 mm in the test group 2. No statistically significant difference between the groups was found for both clinical and radiographic outcomes.
At 6 months, lamina dura was detected in one site in a patient belonging to group 1, whilst 12 months after surgery it was detected in three sites, ("two sites from group 1 and one site from group 2.") Plaque, together bleeding on probing, was found at the site of intervention in four sites and in one site respectively, 6 and 12 months after surgery. The relatively low number of sites with bleeding on probing and plaque deposits prevented us from making statistical inferences on these variables.
All baseline radiographic parameters (CEJ-A, C-A, C-B) were significantly related with changes in both clinical and radiographic outcomes 6 months after intervention. Baseline PD and CAL were also related to clinical and radiographic outcomes changes.
DISCUSSION
In the present study, EMD alone and EMD combined with an adjunctive bone substitute (DBBM) were successfully used for the treatment of partially contained intrabony defects.
Some differences could be found in the short-term radiographic outcomes and they could be due to the radiographic characteristics of the bone substitute rather than to a significant difference in periodontal regeneration. Conversely, no statistically significant difference between groups was found for both clinical and radiographic outcomes at 12-month follow-up. The choice of presenting also short-term results was coherent to the one made in other similar studies about regenerative treatment of periodontal intrabony defects, [24] [25] [26] as they might be useful to evaluate hard and soft tissue healing without a substantial influence of oral hygiene and, in general, of the adherence of the subject to maintenance protocol. Looking at the existing scientific literature, there are many clinical trials that have explored the efficacy of EMD for the treatment of intrabony defects 17 . 27, 28 One study on 172 subjects, comparing the use of EMD with open flap debridement (OFD) alone, found a significant advantage for the use of EMD, resulting in a mean PD reduction of 3.9 AE 1.7 mm and CAL gain of 3.1 AE 1.5 mm 12 months after surgery, 29 and these outcomes are comparable to those obtained in our study. Similar results were also confirmed by other authors that compared EMD and OFD. 30, 31 Several comparative studies have previously explored the efficacy of using EMD alone or in combination with bone substitutes for the treatment of intrabony defects. One systematic review on this particular topic was published by Matarasso et al. in 2015. 18 A total of 12 articles were included in the quantitative analysis, four of which compared EMD to EMD + DBBM. 24, 25, 32, 33 One of these studies showed a significant benefit of the use of a combination of EMD and DBBM with regard to PD and CAL changes. 25 Conversely, the other three studies reported no differences between the two groups and the results were comparable to those obtained in the present study. Interestingly, two studies found a higher recession in the group where EMD was used alone. 25, 32 It is however important to highlight that a significant dispersion of the REC parameter was observed in our study, as confirmed by the relatively high standard deviation.
A recent randomized controlled clinical trial compared the use of EMD alone to EMD as an adjunct to a bone substitute (biphasic calcium phosphate) for the treatment of non-contained intrabony defects. 34 Even though the bone substitute material used was different from the one used in our investigation, the reported results could be compared to the ones obtained in the present study. In fact, at 6 months, the authors found no differences between the two groups for all clinical parameters (PD, REC and CAL). In our investigation, a tendency for higher changes in PD and CAL was noticed as compared to the study by Losada et al. 34 Nevertheless, as previously mentioned, this tendency did not reach statistical significance for either of the outcomes. On the other hand, changes in REC were similar.
We speculate that the lack of a significant difference between test groups, in which partially contained defects were treated, was related to the regenerative capabilities of EMD and to the application of a papilla preservation technique. Actually, we obtained similar results to the ones presented by Cortellini in 2011, 33 who used the same papilla preservation technique. A systematic review on OFD published by Graziani in 2012 35 showed that studies using a papilla preservation technique show better outcomes than studies with OFD without papilla preservation, assuming that the primary closure obtained without papilla resection could improve clot stability. The effect of the surgical technique on the treatment outcome of non-contained and partially contained defects should be further explored in randomized controlled clinical trials. CEJ-A, distance between the cemento-enamel junction and the bottom of the defect; C-A, distance between the projection of the bone crest to the root surface and the bottom of the defect; C-B, distance between the bone crest and the root surface (representing the maximum width of the defect. Mean values AE standard deviation are presented.
Some issues could be considered, to account for the external validity of the obtained results. Although no study-specific sample size calculation was performed, the number of patients included in this study is in line with previous studies investigating the surgical treatment of intrabony defects. 25, 33, [36] [37] [38] In conclusion, despite the aforementioned limitations, this study showed positive clinical and radiographic outcomes when partially contained intrabony defects were treated with EMD alone and EMD + DBBM, and the results obtained were comparable between groups at 12-month follow-up. We can also hypothesize that the application of papilla preservation flaps could lower the need of associating DBBM to EMD in partially contained defects. More studies with a randomized comparative design are needed to clarify the effect of flap design on clinical and radiographic outcomes and to explore the usefulness of a modification of the classification scheme used for periodontal intrabony defects.
